Evaluation of nanomedicines: stick to the basics
Crossref DOI link: https://doi.org/10.1038/natrevmats.2016.73
Published Online: 2016-09-13
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McNeil, Scott E.
Text and Data Mining valid from 2016-09-13
Version of Record valid from 2016-09-13
Article History
First Online: 13 September 2016
Competing interests
: The author declares no competing interests. Celator Pharmaceuticals, Inc. is a former NCL collaborator.